Justin Yorke

Track

Insider profile

Currently holds positions in Processa Pharmaceuticals Inc and Endovia Health Sciences, Inc.

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Processa Pharmaceuticals Inc Aug. 24, 2017 -
Secretary, Director Endovia Health Sciences, Inc. March 31, 2020 -
Justin Yorke's trades of Processa Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
118.04
Quantity 35,081 +24.4%
Value US$1,291,668
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-31 2025-01-27
B Purchase
35,081 +24.4%
118.04
US$1,291,668 		35,081 +24.4% 118.04 US$1,291,668
2024-01-31 2024-01-30
B Purchase
56,818 -23.7%
171.28
US$3,328,664 		56,818 -23.7% 171.28 US$3,328,664
2022-01-31 2022-01-27
S Sale
39,713 -0.8%
33.26
US$2,010,206 		39,713 -0.8% 33.26 US$2,010,206
2021-12-07 2021-12-06
S Sale
4,200 -0.8%
4.71
US$19,784 		4,200 -0.8% 4.71 US$19,784
2021-12-07 2021-12-03
S Sale
5,500 -1.0%
4.84
US$26,599 		5,500 -1.0% 4.84 US$26,599